Pointe-Claire, Canada

Alexander Perryman

USPTO Granted Patents = 1 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Alexander Perryman

Introduction

Alexander Perryman is a notable inventor based in Pointe-Claire, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that may aid in medical treatments. His work focuses on innovative solutions that address critical health issues.

Latest Patents

Perryman holds a patent for "Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use." This patent discloses compounds and pharmaceutically acceptable salts that can be utilized in treating subjects in need. The compounds are identified as inhibitors of tyrosine and threonine-specific cdc2-inhibitory kinase (Myt1). Additionally, the patent includes pharmaceutical compositions containing these compounds and methods for their preparation and use.

Career Highlights

Throughout his career, Alexander Perryman has demonstrated a commitment to advancing pharmaceutical science. His innovative approach has led to the development of new therapeutic options that could potentially improve patient outcomes. He is currently associated with Repare Therapeutics Inc., where he continues to work on groundbreaking research.

Collaborations

Perryman collaborates with talented individuals in his field, including Janek Szychowski and Bingcan Liu. These partnerships enhance the research and development process, fostering an environment of creativity and innovation.

Conclusion

Alexander Perryman's contributions to pharmaceutical inventions highlight his role as a key innovator in the industry. His patent work and collaborations reflect a dedication to improving healthcare through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…